Contrast injector systems are devices that enhance the visibility of body structures, such as body fluids, tissues, bones, veins, and arteries for diagnosis of diseases. These systems utilize contrast media to improve imaging of body structures. The visualization of various pathologies is done through imaging procedures, such as computed tomography (CT), magnetic resonance imaging (MRI), and angiography. These devices are popularly used for the treatment of various chronic diseases, such as cancer, Alzheimer's, and dementia. For instance, it is used to improve the visibility of blood vessels and gastrointestinal tract.
The major factors that drive the growth of the global contrast injector systems market include, rapid use of medical imaging process through contrast injectors, such as angiography, computed tomography, and magnetic resonance imaging procedures. In addition, increase in geriatric population and high prevalence of chronic diseases globally, propel the market growth. However, high cost associated with contrast injector systems and risks related to injector systems and contrast media are expected to restrict the market growth.
The contrast injector systems market is segmented on the basis of product type, application, end user, and region. According to product type, the market is divided into injector systems, consumables, and accessories. On the basis of application, the market is divided into interventional radiology, interventional cardiology, and radiology. On the basis of end user, the market is bifurcated, diagnostic centers, clinics, hospitals, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA).
The major companies profiled in the report include, Bracco Imaging S.p.A, Bayer HealthCare, Guerbet Group, Medtron AG, Ulrich GmbH & Co. KG, GE Healthcare, Shenzhen Seacrown Electromechanical Co., Ltd, Nemoto Kyorindo Co. Ltd., Sino Medical- Device Technology Co., Ltd., and Vivid Imaging.
The major factors that drive the growth of the global contrast injector systems market include, rapid use of medical imaging process through contrast injectors, such as angiography, computed tomography, and magnetic resonance imaging procedures. In addition, increase in geriatric population and high prevalence of chronic diseases globally, propel the market growth. However, high cost associated with contrast injector systems and risks related to injector systems and contrast media are expected to restrict the market growth.
The contrast injector systems market is segmented on the basis of product type, application, end user, and region. According to product type, the market is divided into injector systems, consumables, and accessories. On the basis of application, the market is divided into interventional radiology, interventional cardiology, and radiology. On the basis of end user, the market is bifurcated, diagnostic centers, clinics, hospitals, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA).
The major companies profiled in the report include, Bracco Imaging S.p.A, Bayer HealthCare, Guerbet Group, Medtron AG, Ulrich GmbH & Co. KG, GE Healthcare, Shenzhen Seacrown Electromechanical Co., Ltd, Nemoto Kyorindo Co. Ltd., Sino Medical- Device Technology Co., Ltd., and Vivid Imaging.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the contrast injector systems market analysis from 2020 to 2030 to identify the prevailing contrast injector systems market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the contrast injector systems market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global contrast injector systems market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly update (only available with the purchase of an enterprise license)
- 5 additional company profiles of your choice, pre- or post-purchase, as a free update.
- Free updated version (once released) with the purchase of a 1-5 or enterprise user license.
- 16 analyst hours of support (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% free customization (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
- Free data pack (Excel version) with the purchase of a 1-5 or enterprise user license.
- Free report update, if the report is 6-12 months old or older.
- 24-hour priority response
- Free industry updates and white papers.
Key Market Segments
By Product Type
- Consumables
- Injector Systems
- Accessories
By Application
- Radiology
- Interventional Radiology
- Interventional Cardiology
By End User
- Diagnostics centers
- Clinics
- Others
- Hospitals
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Medtron AG
- Bayer Healthcare LLC
- Nemoto Kyorindo Co. Ltd.
- Sino Medical- Device Technology Co., Ltd.
- Vivid Imaging
- Ulrich GmbH & Co. KG
- Guerbet Group
- GE Healthcare
- Bracco Imaging S.p.A
- Shenzhen Seacrown Electromechanical Co., Ltd.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE
CHAPTER 5: CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION
CHAPTER 6: CONTRAST INJECTOR SYSTEMS MARKET, BY END USER
CHAPTER 7: CONTRAST INJECTOR SYSTEMS MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to this report, the contrast injector systems market was valued at $755.57 million in 2020, and is estimated to reach $1.5 billion by 2030, growing at a CAGR of 7.3% from 2021 to 2030.Contrast injector system is a medical diagnostic device that uses a contrast medium to create visual representations of the human body's interior to diagnose, monitor, or treat clinical problems. Computed tomography, magnetic resonance imaging, and angiography are three of the most common imaging procedures. When compared to typical image processing, the contrast media improves the contrast structures or visibility of fluids within the body. It is utilized to make blood vessels and the gastrointestinal tract more visible.
Increase in imaging procedures, owing to the rapid incidence of various chronic diseases, such as cancer, heart diseases, Alzheimer’s, and dementia is expected to drive the contrast injector systems market size. In addition, rise in increase in geriatric population and high prevalence of chronic diseases globally, boost the market growth. However, high cost of contrast injectors systems and high risk associated with contrast injector systems are expected to impede the growth in contrast injector systems market forecast. Moreover, surge in healthcare expenditure and emergence of complex diseases in developing countries are expected to create lucrative opportunities for key market player and driving the contrast injector systems industry.
On the basis of product type, the contrast injector systems market analysis is categorized as injector systems, consumables, and accessories. The consumable segment is expected to dominate the contrast injector systems market size during the forecast period, owing to the growth in number of imaging procedures, such as CT, MRI, and angiography. The injector systems segment is expected to register a CAGR of 7.6% during the forecast period. Rise in incidence of chronic ailments, such as various types of cancer, Alzheimer’s, and dementia is expected to create a demand for diagnostic procedures for precise treatment, which is expected to drive the growth of the market during the forecast period.
On the basis of application, the interventional radiology segment accounted for a major share of the market share in the global contrast injector system market in 2020. This segment is expected to exhibit a prominent growth rate, owing to reduced risks, lower cost, higher level of comfort, shorter hospital stays, and quicker recovery. These factors driving the contrast injector systems market size.
On the basis of end user, the hospital segment accounted for a major share of the market share in the global contrast injector system market in 2020. This segment is expected to exhibit a prominent growth rate, as the onset of complex diseases among the population base has necessitated the need for detailed examination and early diagnosis pattern of diseases, in turn increasing the installation for contrast injector systems. This has further led to rise in number of procedures performed, especially CT scan, thus, supplementing the growth of this segment.
North America accounted for more than 7.5% of the global market share in 2020, and is expected to remain dominant during the forecast period. This was attributed to the research activities for contrast injector system, which are soaring in North America, owing to the well-established healthcare facilities, recent technological advancements, and rise in demand for early diagnosis of chronic diseases due to increase in awareness regarding contrast injectors. Asia-Pacific is projected to register the highest CAGR of 8.1% during the forecast period, owing to increase in incidence of population suffering from various chronic diseases, such as cancer, heart diseases, Alzheimer’s, and dementia and rise in ageing population. In addition, increase in healthcare expenditure offers a lucrative opportunity for the contrast injector systems market share.
The major companies profiled in the report include, Bracco Imaging S. p.A, Bayer HealthCare, Guerbet Group, Medtron AG, Ulrich GmbH & Co. KG, GE Healthcare, Shenzhen Seacrown Electromechanical Co., Ltd, Nemoto Kyorindo Co. Ltd., Sino Medical- Device Technology Co., Ltd., and Vivid Imaging.
The overall impact of COVID-19 remains negative on the contrast injector system market, owing to decline in number of geriatric patient visits in hospitals & clinics for various chronic diseases, such as cancer, heart diseases, Alzheimer’s, and dementia. In addition, number of patients coming for CT and MRI also declined, as these patients are more vulnerable to the COVID-19 infection, which led to decline in demand for contrast injector system products.
KEY FINDINGS OF THE STUDY
By product type, the consumables segment is expected to experience rapid growth in the market, and is projected to grow at a CAGR of 7.2% from 2021 to 2030.By application, interventional radiology is projected to grow at a CAGR of 7.0% during the forecast period.
By end user, the hospital segment is expected to experience growth at the highest rate, registering a CAGR of 7.4% during the forecast period.
Region-wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 8.1% during the forecast period.
ued at $755.57 million in 2020, and is estimated to reach $1.5 billion by 2030, growing at a CAGR of 7.3% from 2021 to 2030.
Companies Mentioned
- Medtron AG
- Bayer Healthcare LLC
- Nemoto Kyorindo Co. Ltd.
- Sino Medical- Device Technology Co., Ltd.
- Vivid Imaging
- Ulrich GmbH & Co. KG
- Guerbet Group
- GE Healthcare
- Bracco Imaging S.p.A
- Shenzhen Seacrown Electromechanical Co., Ltd.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
